| Year |
Citation |
Score |
| 2020 |
Young JA, Henry BE, Benencia F, Bell S, List EO, Kopchick JJ, Berryman DE. GHR Mice are protected from obesity-related white adipose tissue inflammation. Journal of Neuroendocrinology. e12854. PMID 32350959 DOI: 10.1111/Jne.12854 |
0.391 |
|
| 2020 |
McCall KD, Muccioli M, Benencia F. Toll-Like Receptors Signaling in the Tumor Microenvironment. Advances in Experimental Medicine and Biology. 1223: 81-97. PMID 32030686 DOI: 10.1007/978-3-030-35582-1_5 |
0.825 |
|
| 2019 |
Phillippi B, Singh M, Loftus T, Smith H, Muccioli M, Wright J, Pate M, Benencia F. Effect of laminin environments and tumor factors on the biology of myeloid dendritic cells. Immunobiology. PMID 31753553 DOI: 10.1016/J.Imbio.2019.10.003 |
0.832 |
|
| 2019 |
Dangaj D, Bruand M, Grimm AJ, Ronet C, Barras D, Duttagupta PA, Lanitis E, Duraiswamy J, Tanyi JL, Benencia F, Conejo-Garcia J, Ramay HR, Montone KT, Powell DJ, Gimotty PA, et al. Cooperation between Constitutive and Inducible Chemokines Enables T Cell Engraftment and Immune Attack in Solid Tumors. Cancer Cell. 35: 885-900.e10. PMID 31185212 DOI: 10.1016/J.Ccell.2019.05.004 |
0.592 |
|
| 2018 |
Muccioli M, Nandigam H, Loftus T, Singh M, Venkatesh A, Wright J, Pate M, McCall K, Benencia F. Modulation of double-stranded RNA pattern recognition receptor signaling in ovarian cancer cells promotes inflammatory queues. Oncotarget. 9: 36666-36683. PMID 30613350 DOI: 10.18632/Oncotarget.26378 |
0.829 |
|
| 2018 |
Sprague L, Braidwood L, Conner J, Cassady KA, Benencia F, Cripe TP. Please stand by: how oncolytic viruses impact bystander cells. Future Virology. 13: 671-680. PMID 30416535 DOI: 10.2217/Fvl-2018-0068 |
0.397 |
|
| 2017 |
Venkatesh A, Nandigam H, Muccioli M, Singh M, Loftus T, Lewis D, Pate M, Benencia F. Regulation of inflammatory factors by double-stranded RNA receptors in breast cancer cells. Immunobiology. PMID 29331323 DOI: 10.1016/J.Imbio.2017.11.005 |
0.834 |
|
| 2017 |
Carlson GE, Ostermann AO, Shirure VS, Benencia F, Burdick MM. Abstract 866: The epithelial-to-mesenchymal transition regulates E-selectin ligand activities of breast cancer cells Cancer Research. 77: 866-866. DOI: 10.1158/1538-7445.Am2017-866 |
0.356 |
|
| 2016 |
Singh M, Loftus T, Webb E, Benencia F. Minireview: Regulatory T Cells and Ovarian Cancer. Immunological Investigations. 1-9. PMID 27420920 DOI: 10.1080/08820139.2016.1186689 |
0.569 |
|
| 2016 |
Carlson GE, Shirure V, Ostermann AO, Blaha EA, Delgadillo LF, Tees DFJ, Benencia F, Burdick M. Abstract 1609: The epithelial to mesenchymal transition regulates the expression of E-selectin ligands on breast cancer cell lines Cancer Research. 76: 1609-1609. DOI: 10.1158/1538-7445.Am2016-1609 |
0.402 |
|
| 2015 |
Block KI, Gyllenhaal C, Lowe L, Amedei A, Amin AR, Amin A, Aquilano K, Arbiser J, Arreola A, Arzumanyan A, Ashraf SS, Azmi AS, Benencia F, Bhakta D, Bilsland A, et al. Designing a broad-spectrum integrative approach for cancer prevention and treatment. Seminars in Cancer Biology. 35: S276-304. PMID 26590477 DOI: 10.1016/J.Semcancer.2015.09.007 |
0.394 |
|
| 2015 |
Adams SF, Benencia F. Immunotherapy for ovarian cancer: what are the targets of the future? Future Oncology (London, England). 11: 1293-6. PMID 25952776 DOI: 10.2217/Fon.15.44 |
0.359 |
|
| 2015 |
Olarescu NC, Berryman DE, Householder LA, Lubbers ER, List EO, Benencia F, Kopchick JJ, Bollerslev J. GH action influences adipogenesis of mouse adipose tissue-derived mesenchymal stem cells. The Journal of Endocrinology. 226: 13-23. PMID 25943560 DOI: 10.1530/Joe-15-0012 |
0.339 |
|
| 2015 |
Casey SC, Amedei A, Aquilano K, Azmi AS, Benencia F, Bhakta D, Bilsland AE, Boosani CS, Chen S, Ciriolo MR, Crawford S, Fujii H, Georgakilas AG, Guha G, Halicka D, et al. Cancer prevention and therapy through the modulation of the tumor microenvironment. Seminars in Cancer Biology. PMID 25865775 DOI: 10.1016/J.Semcancer.2015.02.007 |
0.572 |
|
| 2015 |
Benencia F, Harshman S, Duran-Ortiz S, Lubbers ER, List EO, Householder L, Al-Naeeli M, Liang X, Welch L, Kopchick JJ, Berryman DE. Male bovine GH transgenic mice have decreased adiposity with an adipose depot-specific increase in immune cell populations. Endocrinology. 156: 1794-803. PMID 25521584 DOI: 10.1210/En.2014-1794 |
0.424 |
|
| 2015 |
Shirure VS, Liu T, Delgadillo LF, Cuckler CM, Tees DF, Benencia F, Goetz DJ, Burdick MM. CD44 variant isoforms expressed by breast cancer cells are functional E-selectin ligands under flow conditions. American Journal of Physiology. Cell Physiology. 308: C68-78. PMID 25339657 DOI: 10.1152/Ajpcell.00094.2014 |
0.4 |
|
| 2015 |
Singh M, Benencia F. Minireview: Optimization of Human Dendritic Cells for Antitumor Vaccination Moj Immunology. 2. DOI: 10.15406/Moji.2015.2.00065 |
0.512 |
|
| 2014 |
Muccioli M, Benencia F. Toll-like Receptors in Ovarian Cancer as Targets for Immunotherapies. Frontiers in Immunology. 5: 341. PMID 25101083 DOI: 10.3389/Fimmu.2014.00341 |
0.826 |
|
| 2014 |
Motz GT, Santoro SP, Wang LP, Garrabrant T, Lastra RR, Hagemann IS, Lal P, Feldman MD, Benencia F, Coukos G. Tumor endothelium FasL establishes a selective immune barrier promoting tolerance in tumors. Nature Medicine. 20: 607-15. PMID 24793239 DOI: 10.1038/Nm.3541 |
0.58 |
|
| 2014 |
Benencia F, Muccioli M, Alnaeeli M. Perspectives on reprograming cancer-associated dendritic cells for anti-tumor therapies. Frontiers in Oncology. 4: 72. PMID 24778991 DOI: 10.3389/Fonc.2014.00072 |
0.841 |
|
| 2014 |
Benencia F. Antigen-specific mRNA transfection of autologous dendritic cells. Methods in Molecular Biology (Clifton, N.J.). 1139: 77-86. PMID 24619672 DOI: 10.1007/978-1-4939-0345-0_8 |
0.547 |
|
| 2014 |
Walkowski S, Singh M, Puertas J, Pate M, Goodrum K, Benencia F. Osteopathic manipulative therapy induces early plasma cytokine release and mobilization of a population of blood dendritic cells. Plos One. 9: e90132. PMID 24614605 DOI: 10.1371/Journal.Pone.0090132 |
0.379 |
|
| 2014 |
Sprague L, Muccioli M, Pate M, Singh M, Xiong C, Ostermann A, Niese B, Li Y, Li Y, Courreges MC, Benencia F. Dendritic cells: In vitro culture in two- and three-dimensional collagen systems and expression of collagen receptors in tumors and atherosclerotic microenvironments. Experimental Cell Research. 323: 7-27. PMID 24569142 DOI: 10.1016/J.Yexcr.2014.01.031 |
0.813 |
|
| 2014 |
Mohammadalipour A, Benencia F, Burdick MM, Tees DFJ. Abstract 1922: Elasticity of stem-like and non-stem-like breast cancer cells studied by micropipette aspiration technique Cancer Research. 74: 1922-1922. DOI: 10.1158/1538-7445.Am2014-1922 |
0.402 |
|
| 2014 |
Carlson GE, Delgadillo LF, Blaha EA, Benencia F, Burdick MM. Abstract 1920: Stem-like triple negative breast cancer cells exhibit a distinct response to selectin/selectin ligand interactions Cancer Research. 74: 1920-1920. DOI: 10.1158/1538-7445.Am2014-1920 |
0.42 |
|
| 2014 |
Muccioli M, Pate M, Benencia F. Abstract 1659: Characterizing cytokine secretion in response to dsRNA treatment in ovarian cancer cells Cancer Research. 74: 1659-1659. DOI: 10.1158/1538-7445.Am2014-1659 |
0.809 |
|
| 2013 |
McCall KD, Schmerr MJ, Thuma JR, James CB, Courreges MC, Benencia F, Malgor R, Schwartz FL. Phenylmethimazole suppresses dsRNA-induced cytotoxicity and inflammatory cytokines in murine pancreatic beta cells and blocks viral acceleration of type 1 diabetes in NOD mice. Molecules (Basel, Switzerland). 18: 3841-58. PMID 23535518 DOI: 10.3390/Molecules18043841 |
0.344 |
|
| 2013 |
Osterbur J, Sprague L, Muccioli M, Pate M, Mansfield K, McGinty J, Li Y, Li Y, Shirure V, Courreges MC, Benencia F. Adhesion to substrates induces dendritic cell endothelization and decreases immunological response. Immunobiology. 218: 64-75. PMID 22551928 DOI: 10.1016/J.Imbio.2012.02.003 |
0.821 |
|
| 2013 |
Muccioli M, Pate M, Benencia F. Abstract A65: Toll-like receptor 3 signaling in ovarian cancer. Cancer Research. 73. DOI: 10.1158/1538-7445.Tumimm2012-A65 |
0.818 |
|
| 2013 |
Mohammadalipour A, Benencia F, Burdick MM, Tees DFJ. Abstract 3766: Mechanical properties of cancer cells: a possible biomarker for stemness. Cancer Research. 73: 3766-3766. DOI: 10.1158/1538-7445.Am2013-3766 |
0.412 |
|
| 2013 |
Shirure VS, Xiong C, Benencia F, Burdick MM. Abstract 204: Breast cancer stem and non-stem-like cells express varying levels of selectin ligand activities. Cancer Research. 73: 204-204. DOI: 10.1158/1538-7445.Am2013-204 |
0.445 |
|
| 2012 |
Burdick MM, Henson KA, Delgadillo LF, Choi YE, Goetz DJ, Tees DF, Benencia F. Expression of E-selectin ligands on circulating tumor cells: cross-regulation with cancer stem cell regulatory pathways? Frontiers in Oncology. 2: 103. PMID 22934288 DOI: 10.3389/Fonc.2012.00103 |
0.515 |
|
| 2012 |
Muccioli M, Longstaff C, Benencia F. Absence of CD4 T-cell help provides a robust CD8 T-cell response while inducing effective memory in a preclinical model of melanoma. Immunotherapy. 4: 477-81. PMID 22642330 DOI: 10.2217/Imt.12.39 |
0.736 |
|
| 2012 |
Muccioli M, Sprague L, Nandigam H, Pate M, Benencia F. Toll-like receptors as novel therapeutic targets for ovarian cancer. Isrn Oncology. 2012: 642141. PMID 22530148 DOI: 10.5402/2012/642141 |
0.812 |
|
| 2012 |
Benencia F, Sprague L, McGinty J, Pate M, Muccioli M. Dendritic cells the tumor microenvironment and the challenges for an effective antitumor vaccination. Journal of Biomedicine & Biotechnology. 2012: 425476. PMID 22505809 DOI: 10.1155/2012/425476 |
0.812 |
|
| 2012 |
Delgadillo LF, Shirure VS, Liu T, Goetz DJ, Benencia F, Burdick MM. Abstract 5181: Dynamic cellular adhesivity of breast cancer cells conferred by CD44 varies with mesenchymal or epithelial phenotype Cancer Research. 72: 5181-5181. DOI: 10.1158/1538-7445.Am2012-5181 |
0.428 |
|
| 2011 |
Muccioli M, Pate M, Omosebi O, Benencia F. Generation and labeling of murine bone marrow-derived dendritic cells with Qdot nanocrystals for tracking studies. Journal of Visualized Experiments : Jove. PMID 21673641 DOI: 10.3791/2785 |
0.756 |
|
| 2011 |
Sprague L, Muccioli M, Pate M, Meles E, McGinty J, Nandigam H, Venkatesh AK, Gu MY, Mansfield K, Rutowski A, Omosebi O, Courreges MC, Benencia F. The interplay between surfaces and soluble factors define the immunologic and angiogenic properties of myeloid dendritic cells. Bmc Immunology. 12: 35. PMID 21645356 DOI: 10.1186/1471-2172-12-35 |
0.807 |
|
| 2011 |
Alagkiozidis I, Facciabene A, Tsiatas M, Carpenito C, Benencia F, Adams S, Jonak Z, June CH, Powell DJ, Coukos G. Time-dependent cytotoxic drugs selectively cooperate with IL-18 for cancer chemo-immunotherapy. Journal of Translational Medicine. 9: 77. PMID 21609494 DOI: 10.1186/1479-5876-9-77 |
0.426 |
|
| 2010 |
Chiang CL, Benencia F, Coukos G. Whole tumor antigen vaccines. Seminars in Immunology. 22: 132-43. PMID 20356763 DOI: 10.1016/J.Smim.2010.02.004 |
0.552 |
|
| 2010 |
Franco LG, Feledi CA, Massouh EJ, Benencia F. Aminoguanidine administered during the induction of oral tolerance alters the systemic response of the tolerised rats. Cellular Immunology. 261: 42-50. PMID 19931043 DOI: 10.1016/J.Cellimm.2009.10.010 |
0.309 |
|
| 2010 |
Venkatesh AK, Pate M, Benencia F. Abstract 1333: Upregulation of chemokines including RANTES/CCL5 upon Toll-like receptor 3 activation in breast cancer: Association with leukocyte infiltration Cancer Research. 70: 1333-1333. DOI: 10.1158/1538-7445.Am10-1333 |
0.368 |
|
| 2009 |
Alagkiozidis I, Facciabene A, Carpenito C, Benencia F, Jonak Z, Adams S, Carroll RG, Gimotty PA, Hammond R, Danet-Desnoyers GÄ, June CH, Powell DJ, Coukos G. Increased immunogenicity of surviving tumor cells enables cooperation between liposomal doxorubicin and IL-18. Journal of Translational Medicine. 7: 104. PMID 20003308 DOI: 10.1186/1479-5876-7-104 |
0.581 |
|
| 2009 |
Christian NA, Benencia F, Milone MC, Li G, Frail PR, Therien MJ, Coukos G, Hammer DA. In vivo dendritic cell tracking using fluorescence lifetime imaging and near-infrared-emissive polymersomes. Molecular Imaging and Biology : Mib : the Official Publication of the Academy of Molecular Imaging. 11: 167-77. PMID 19194761 DOI: 10.1007/S11307-008-0184-X |
0.387 |
|
| 2008 |
Markiewski MM, DeAngelis RA, Benencia F, Ricklin-Lichtsteiner SK, Koutoulaki A, Gerard C, Coukos G, Lambris JD. Modulation of the antitumor immune response by complement. Nature Immunology. 9: 1225-35. PMID 18820683 DOI: 10.1038/Ni.1655 |
0.571 |
|
| 2008 |
Huarte E, Cubillos-Ruiz JR, Nesbeth YC, Scarlett UK, Martinez DG, Buckanovich RJ, Benencia F, Stan RV, Keler T, Sarobe P, Sentman CL, Conejo-Garcia JR. Depletion of dendritic cells delays ovarian cancer progression by boosting antitumor immunity. Cancer Research. 68: 7684-91. PMID 18768667 DOI: 10.1158/0008-5472.Can-08-1167 |
0.641 |
|
| 2008 |
Benencia F, Courrèges MC, Fraser NW, Coukos G. Herpes virus oncolytic therapy reverses tumor immune dysfunction and facilitates tumor antigen presentation Cancer Biology and Therapy. 7: 1194-1205. PMID 18458533 DOI: 10.4161/Cbt.7.8.6216 |
0.622 |
|
| 2008 |
Christman MA, Goetz DJ, Dickerson E, McCall KD, Lewis CJ, Benencia F, Silver MJ, Kohn LD, Malgor R. Wnt5a is expressed in murine and human atherosclerotic lesions. American Journal of Physiology. Heart and Circulatory Physiology. 294: H2864-70. PMID 18456733 DOI: 10.1152/Ajpheart.00982.2007 |
0.348 |
|
| 2008 |
Benencia F, Courrèges MC, Coukos G. Whole tumor antigen vaccination using dendritic cells: comparison of RNA electroporation and pulsing with UV-irradiated tumor cells. Journal of Translational Medicine. 6: 21. PMID 18445282 DOI: 10.1186/1479-5876-6-21 |
0.583 |
|
| 2008 |
Buckanovich RJ, Facciabene A, Kim S, Benencia F, Sasaroli D, Balint K, Katsaros D, O'Brien-Jenkins A, Gimotty PA, Coukos G. Endothelin B receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy. Nature Medicine. 14: 28-36. PMID 18157142 DOI: 10.1038/Nm1699 |
0.639 |
|
| 2008 |
Markiewski M, DeAngelis R, Benencia F, Ricklin-Lichtsteiner S, Koutoulaki A, Coukos G, Lambris J. Modulation of the anti-tumour immune response by complement Molecular Immunology. 45: 4151. DOI: 10.1016/J.Molimm.2008.08.166 |
0.327 |
|
| 2007 |
Coukos G, Conejo-Garcia JR, Buckanovich R, Benencia F. Vascular leukocytes: a population with angiogenic and immunossuppressive properties highly represented in ovarian cancer. Advances in Experimental Medicine and Biology. 590: 185-93. PMID 17191386 DOI: 10.1007/978-0-387-34814-8_13 |
0.361 |
|
| 2006 |
Benencia F, Courrèges MC, Conejo-García JR, Mohammed-Hadley A, Coukos G. Direct vaccination with tumor cells killed with ICP4-deficient HSVd120 elicits effective antitumor immunity. Cancer Biology & Therapy. 5: 867-74. PMID 16861891 DOI: 10.4161/Cbt.5.7.2908 |
0.61 |
|
| 2006 |
Buckanovich RJ, Sasaroli D, O'brien-Jenkins A, Botbyl J, Conejo-Garcia JR, Benencia F, Liotta LA, Gimotty PA, Coukos G. Use of immuno-LCM to identify the in situ expression profile of cellular constituents of the tumor microenvironment. Cancer Biology & Therapy. 5: 635-42. PMID 16627987 DOI: 10.4161/Cbt.5.6.2676 |
0.572 |
|
| 2006 |
Courrèges MC, Benencia F, Conejo-García JR, Zhang L, Coukos G. Preparation of apoptotic tumor cells with replication-incompetent HSV augments the efficacy of dendritic cell vaccines. Cancer Gene Therapy. 13: 182-93. PMID 16138121 DOI: 10.1038/Sj.Cgt.7700888 |
0.613 |
|
| 2006 |
Buckanovich RJ, Kim S, Benencia F, Sasaroli D, Gimotty P, Coukos G. Endothelin receptor B predicts poor prognosis in epithelial ovarian cancer (EOC) and can be inhibited to increase intratumoral T cells and enhance tumor vaccine therapy Journal of Clinical Oncology. 24: 2524-2524. DOI: 10.1200/Jco.2006.24.18_Suppl.2524 |
0.568 |
|
| 2005 |
Benencia F, Courreges MC, Conejo-García JR, Buckanovich RJ, Zhang L, Carroll RH, Morgan MA, Coukos G. Oncolytic HSV exerts direct antiangiogenic activity in ovarian carcinoma. Human Gene Therapy. 16: 765-78. PMID 15960607 DOI: 10.1097/00002371-200411000-00029 |
0.48 |
|
| 2005 |
Benencia F, Courrèges MC, Conejo-García JR, Mohamed-Hadley A, Zhang L, Buckanovich RJ, Carroll R, Fraser N, Coukos G. HSV oncolytic therapy upregulates interferon-inducible chemokines and recruits immune effector cells in ovarian cancer. Molecular Therapy : the Journal of the American Society of Gene Therapy. 12: 789-802. PMID 15925544 DOI: 10.1016/J.Ymthe.2005.03.026 |
0.56 |
|
| 2005 |
Coukos G, Benencia F, Buckanovich RJ, Conejo-Garcia JR. The role of dendritic cell precursors in tumour vasculogenesis. British Journal of Cancer. 92: 1182-7. PMID 15785750 DOI: 10.1038/Sj.Bjc.6602476 |
0.427 |
|
| 2005 |
Conejo-Garcia JR, Buckanovich RJ, Benencia F, Courreges MC, Rubin SC, Carroll RG, Coukos G. Vascular leukocytes contribute to tumor vascularization. Blood. 105: 679-81. PMID 15358628 DOI: 10.1182/Blood-2004-05-1906 |
0.441 |
|
| 2005 |
Benencia F, Coukos G. T regulatory cell depletion can boost DC-based vaccines Cancer Biology & Therapy. 4: 628-630. DOI: 10.4161/Cbt.4.6.1766 |
0.439 |
|
| 2004 |
Conejo-Garcia JR, Benencia F, Courreges MC, Kang E, Mohamed-Hadley A, Buckanovich RJ, Holtz DO, Jenkins A, Na H, Zhang L, Wagner DS, Katsaros D, Caroll R, Coukos G. Tumor-infiltrating dendritic cell precursors recruited by a beta-defensin contribute to vasculogenesis under the influence of Vegf-A. Nature Medicine. 10: 950-8. PMID 15334073 DOI: 10.1038/Nm1097 |
0.496 |
|
| 2004 |
Conejo-Garcia JR, Benencia F, Courreges MC, Gimotty PA, Khang E, Buckanovich RJ, Frauwirth KA, Zhang L, Katsaros D, Thompson CB, Levine B, Coukos G. Ovarian carcinoma expresses the NKG2D ligand Letal and promotes the survival and expansion of CD28- antitumor T cells. Cancer Research. 64: 2175-82. PMID 15026360 DOI: 10.1158/0008-5472.Can-03-2194 |
0.495 |
|
| 2004 |
Conejo-Garcia J, Benencia F, Coukos G. Tumor-Infiltrating Dendritic Cell Precursors Recruited by a β-Defensin Contribute to Vasculogenesis under the Influence of VEGF-A in Ovarian Cancer Journal of Immunotherapy. 27: S58-S59. DOI: 10.1097/00002371-200411000-00208 |
0.545 |
|
| 2003 |
Conejo-Garcia JR, Benencia F, Courreges MC, Khang E, Zhang L, Mohamed-Hadley A, Vinocur JM, Buckanovich RJ, Thompson CB, Levine B, Coukos G. Letal, A tumor-associated NKG2D immunoreceptor ligand, induces activation and expansion of effector immune cells. Cancer Biology & Therapy. 2: 446-51. PMID 14508119 DOI: 10.4161/Cbt.2.4.479 |
0.604 |
|
| 2003 |
Coukos G, Courreges MC, Benencia F. Intraperitoneal oncolytic and tumor vaccination therapy with replication-competent recombinant virus: the herpes paradigm. Current Gene Therapy. 3: 113-25. PMID 12653405 DOI: 10.2174/1566523034578401 |
0.484 |
|
| 2002 |
Zhang L, Yang N, Garcia JR, Mohamed A, Benencia F, Rubin SC, Allman D, Coukos G. Generation of a syngeneic mouse model to study the effects of vascular endothelial growth factor in ovarian carcinoma. The American Journal of Pathology. 161: 2295-309. PMID 12466143 DOI: 10.1016/S0002-9440(10)64505-1 |
0.563 |
|
| Show low-probability matches. |